Cell of origin of transformed follicular lymphoma

作者: Robert Kridel , Anja Mottok , Pedro Farinha , Susana Ben-Neriah , Daisuke Ennishi

DOI: 10.1182/BLOOD-2015-06-649905

关键词:

摘要: Follicular lymphoma (FL) is an indolent disease but transforms in 2% to 3% of patients per year into aggressive, large cell lymphoma, a critical event the course associated with increased lymphoma-related mortality. Early transformation cannot be accurately predicted at time FL diagnosis and biology transformed (TFL) poorly understood. Here, we assembled cohort 126 diagnostic specimens including 40 experiencing (<5 years) 86 not for least 5 years. In addition, overlapping 155 TFL patients, 114 cases which paired samples were available, assessed temporal changes routinely available biomarkers, outcome after transformation, as well molecular subtypes TFL. We report that expression IRF4 independent predictor early (Hazard ratio, 13.3; P < .001). also show composite histology predicts favorable prognosis. Moreover, applying Lymph2Cx digital gene assay diffuse B-cell (DLBCL) cell-of-origin determination 110 DLBCL-like TFL, demonstrate germinal-center B-cell–like subtype majority (80%) significant proportion activated (ABC) (16%). These latter are commonly negative BCL2 translocation arise preferentially from translocation-negative and/or IRF4-expressing FLs. Our study demonstrates existence heterogeneity its relationship antecedent FL.

参考文章(61)
T Yano, ES Jaffe, DL Longo, M Raffeld, MYC rearrangements in histologically progressed follicular lymphomas Blood. ,vol. 80, pp. 758- 767 ,(1992) , 10.1182/BLOOD.V80.3.758.758
Wyndham H Wilson, Ryan M Young, Roland Schmitz, Yandan Yang, Stefania Pittaluga, George Wright, Chih-Jian Lih, P Mickey Williams, Arthur L Shaffer, John Gerecitano, Sven de Vos, Andre Goy, Vaishalee P Kenkre, Paul M Barr, Kristie A Blum, Andrei Shustov, Ranjana Advani, Nathan H Fowler, Julie M Vose, Rebecca L Elstrom, Thomas M Habermann, Jacqueline C Barrientos, Jesse McGreivy, Maria Fardis, Betty Y Chang, Fong Clow, Brian Munneke, Davina Moussa, Darrin M Beaupre, Louis M Staudt, Targeting B cell receptor signaling with ibrutinib in diffuse large B cell lymphoma Nature Medicine. ,vol. 21, pp. 922- 926 ,(2015) , 10.1038/NM.3884
Elodie Bohers, Sylvain Mareschal, Abdelilah Bouzelfen, Vinciane Marchand, Philippe Ruminy, Catherine Maingonnat, Anne-Lise Ménard, Pascaline Etancelin, Philippe Bertrand, Sydney Dubois, Marion Alcantara, Christian Bastard, Hervé Tilly, Fabrice Jardin, Targetable activating mutations are very frequent in GCB and ABC diffuse large B-cell lymphoma. Genes, Chromosomes and Cancer. ,vol. 53, pp. 144- 153 ,(2014) , 10.1002/GCC.22126
Christian A Sander, Takahiro Yano, Helen M Clark, Cynthia Harris, Dan L Longo, Elaine S Jaffe, Mark Raffeld, None, p53 mutation is associated with progression in follicular lymphomas Blood. ,vol. 82, pp. 1994- 2004 ,(1993) , 10.1182/BLOOD.V82.7.1994.1994
Y Bastion, C Sebban, F Berger, P Felman, G Salles, C Dumontet, P A Bryon, B Coiffier, Incidence, predictive factors, and outcome of lymphoma transformation in follicular lymphoma patients Journal of Clinical Oncology. ,vol. 15, pp. 1587- 1594 ,(1997) , 10.1200/JCO.1997.15.4.1587
Abdulwahab J. Al-Tourah, Karamjit K. Gill, Mukesh Chhanabhai, Paul J. Hoskins, Richard J. Klasa, Kerry J. Savage, Laurie H. Sehn, Tamara N. Shenkier, Randy D. Gascoyne, Joseph M. Connors, Population-Based Analysis of Incidence and Outcome of Transformed Non-Hodgkin's Lymphoma Journal of Clinical Oncology. ,vol. 26, pp. 5165- 5169 ,(2008) , 10.1200/JCO.2008.16.0283
J Fitzgibbon, S Iqbal, A Davies, D O'Shea, E Carlotti, T Chaplin, J Matthews, M Raghavan, A Norton, T A Lister, B D Young, Genome-wide detection of recurring sites of uniparental disomy in follicular and transformed follicular lymphoma Leukemia. ,vol. 21, pp. 1514- 1520 ,(2007) , 10.1038/SJ.LEU.2404696
Paul Shinn, Rajarshi Guha, Marc Ferrer, Craig Thomas, Thomas A. Waldmann, Louis M. Staudt, Yibin Yang, Arthur L. Shaffer, N.C. Tolga Emre, Michele Ceribelli, Meili Zhang, George Wright, Wenming Xiao, John Powell, John Platig, Holger Kohlhammer, Ryan M. Young, Hong Zhao, Yandan Yang, Weihong Xu, Joseph J. Buggy, Sriram Balasubramanian, Lesley A. Mathews, Exploiting Synthetic Lethality for the Therapy of ABC Diffuse Large B Cell Lymphoma Cancer Cell. ,vol. 21, pp. 723- 737 ,(2012) , 10.1016/J.CCR.2012.05.024
H R Junlén, S Peterson, E Kimby, S Lockmer, O Lindén, H Nilsson-Ehle, M Erlanson, H Hagberg, A Rådlund, O Hagberg, B E Wahlin, Follicular lymphoma in Sweden: nationwide improved survival in the rituximab era, particularly in elderly women: a Swedish Lymphoma Registry Study Leukemia. ,vol. 29, pp. 668- 676 ,(2015) , 10.1038/LEU.2014.251
Izidore S. Lossos, Randy D. Gascoyne, Transformation of follicular lymphoma Best Practice & Research Clinical Haematology. ,vol. 24, pp. 147- 163 ,(2011) , 10.1016/J.BEHA.2011.02.006